Terry Bazyluk

Public Communications Contact at Association for Accessible Medicines

Consumer Services

Commercial Services

Profile

Terry Bazyluk is currently the Vice President-Communications at the Association for Accessible Medicines since 2014.
He completed his undergraduate degree at Harvard University and his graduate degree at Yale Law School.

Terry Bazyluk active positions

Companies	Position	Start
Association for Accessible Medicines Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.	Public Communications Contact	2014-11-30

All active positions of Terry Bazyluk

Training of Terry Bazyluk

Harvard University	Undergraduate Degree
Yale Law School	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Terry Bazyluk's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	1
Association for Accessible Medicines Association for Accessible Medicines Miscellaneous Commercial ServicesCommercial Services The Association for Accessible Medicines is an organization that aims to make generic and biosimilar medicines more accessible to those who need them. The organization is based in Arlington, VA. The non-profit company believes that increasing competition is the key to tackling the high cost of prescription drugs, rather than shifting costs among healthcare stakeholders. In 2022, generic and biosimilar prescription medicines saved $408 billion for the healthcare system overall, with more than $2.90 trillion saved over the past 10 years. The company was founded by Milan Puskar, Robert R. Grusky. David Gaugh has been the CEO of the company since 2012.	Commercial Services